A comprehensive view of Sigilon Therapeutics Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Lilly completes acquisition of Sigilon Therapeutics; acquisition allows Lilly to continue researching and developing encapsulated cell therapies, including SIG-002, for the treatment of type 1 diabetes
Published: August 14, 2023 by Eli Lilly & Co.
Eli Lilly to acquire biopharma firm Sigilon Therapeutics for up to $309.6M; the companies have partnered since 2018 to develop encapsulated cell therapies to treat type 1 diabetes
Published: June 29, 2023 by dpa-AFX International Compact

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count